India has invited global pharmaceutical companies to expand their presence in the country, highlighting opportunities in innovation, manufacturing, research and healthcare. The government believes India’s pharmaceutical industry can double in size over the next five years.

BulletsIn

• Union Minister Piyush Goyal invited global pharmaceutical companies to invest in India.
• He addressed the Global Ambassador Meet on the Pharmaceutical Sector in New Delhi.
• India’s pharmaceutical industry is currently valued at around USD 60 billion.
• The sector has the potential to double in size within the next five years.
• India aims to move beyond generic medicines into innovation-driven pharmaceutical products.
• Country continues to position itself as a trusted global healthcare and manufacturing partner.
• India sees opportunities in research, clinical trials, technology and pharmaceutical production.
• Government highlighted India’s role in global pharmaceutical supply chains.
• India remains one of the world’s fastest-growing major economies despite global uncertainties.
• Growing domestic demand and rising incomes are boosting healthcare opportunities.
• The country offers access to a market of more than 1.4 billion people.
• India has signed multiple free trade agreements that improve global market access.
• Several pharmaceutical products receive preferential or zero-duty access under FTAs.
• India supplies affordable generic medicines to millions of patients worldwide.
• Generic medicines account for a major share of medicine volumes used in the United States.
• India supplies a large share of the World Health Organization’s vaccine requirements.
• The country hosts the highest number of US FDA-approved pharma plants outside the United States.
• Patent filings in India have increased significantly in recent years.
• Government launched initiatives such as Biopharma Shakti to support pharmaceutical innovation.
• India emphasized global cooperation for affordable, accessible and sustainable healthcare.